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Abstract
The International Multimorbidity Symposium was held in November 2019 at Western University to achieve three main
objectives: to discuss progress and findings from various jurisdictions; to facilitate collaboration through group dis-
cussion to identify strategies to move multimorbidity research forward; and to create concrete plans to ensure
advances in multimorbidity research and knowledge can be achieved through cross-national partnership. This event
included keynote presentations, elevator pitch presentations and breakout sessions and there was a total of 35
attendees from eight countries, representing diverse disciplines and training levels. The overall themes arising from the
event were: the importance of integrating the study and management of multimorbidity from both the primary care and
public health perspectives; meaningful engagement and collaboration with patients and caregivers to understand key
dimensions of multimorbidity; the considerable benefit of collaborative international partnerships; and the need to
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spread and scale innovations for health care systems that can better respond to the complex needs of patients and
caregivers who are living with multimorbidity. Finally, it was well-acknowledged among the attendees that expanding
the collaboration and discussion among international colleagues via in-person and virtual events will be important to
move multimorbidity research forward.
Keywords
Multimorbidity, research agenda, partnership, cross-national
Received 4 June 2020; accepted: 6 August 2020
Introduction
In recognition of the need to address multimorbidity using
both a population health and primary care perspective,1–3 a
day-long event – The International Multimorbidity Sym-
posium – was held in November 2019 with collaboration
from the Department of Epidemiology and Biostatistics
and the Department of Family Medicine at Western Uni-
versity in London, Ontario, Canada. There were 35 atten-
dees from eight countries (Belgium, Canada, Ireland, The
Netherlands, Russia, Scotland, Singapore and the United
States) and multiple disciplines (including family medicine,
geriatric medicine, internal medicine, nursing, rehabilitation
science, epidemiology, biostatistics, public health and com-
puter science). The attendees included a mix of trainees
(undergraduate, graduate and post-doctoral), clinicians and
researchers (junior, mid-career and senior), which contributed
to the learning and knowledge exchange among attendees
during the symposium.
The overall aim of the symposium was to facilitate
cross-national conversation about ongoing and completed
research in public health and primary care, and to identify
the next steps for key areas of multimorbidity research. The
specific objectives of this symposium were three-fold: to
discuss progress and findings that have already been
achieved in respective jurisdictions and countries of the
participating attendees; to facilitate collaboration through
group brainstorming and discussion to identify strategies to
move multimorbidity research forward; and to create con-
crete plans to ensure advances in multimorbidity research
and knowledge can be achieved through cross-national
partnership, with potential implications for the prevention
and clinical management of multimorbidity .
This symposium also built upon recent events involving
acknowledged experts in multimorbidity, as well as recent
publications that provide a substantial overview of multi-
morbidity knowledge. These resources included the report
from the Academy of Medical Sciences entitled ‘Multimor-
bidity: a priority for global health research’1; the sympo-
sium organized by the Karolinska Institutet International
Symposium entitled ‘Multimorbidity Research at the
Cross-Roads: Developing the Evidence for Clinical Prac-
tice and Health Policy’4,5; and the European General Prac-
tice Research Network (EGPRN) Meeting, which focused
on Research on Multimorbidity in Primary Care.6,7
Keynote presentations
The symposium began with two keynote speakers with
extensive experience in conducting research related to mul-
timorbidity and associated issues (such as disability, frailty
and treatment burden) and who articulated the next priori-
ties for multimorbidity research from both an international
and national perspective. The International Keynote
speaker was Professor Frances Mair (University of Glas-
gow) and the National Keynote speaker was Dr. Lauren
Griffith (McMaster University).
The presentation by Prof. Mair described the challenges
and opportunities of multimorbidity for research and prac-
tice. This included a discussion about the patterns of multi-
morbidity and polypharmacy, risk stratification, treatment
and illness burden for patients and caregivers and the cur-
rently unsuitable structure of the health care systems for
individuals living with multimorbidity. Suggested research
priorities included: 1) understanding mechanisms under-
pinning the development of multimorbidity; 2) exploring
and assessing risks versus benefits of treatment for multi-
morbidity; 3) examining mechanisms underpinning
adverse outcomes in multimorbidity; and 4) investigating
interventions that will best support individuals living with
multimorbidity.
The presentation by Dr. Griffith described the study
of multimorbidity from both a population health and
primary care perspective. This included a discussion of
the epidemiological consequences of different defini-
tions of multimorbidity, population attributable risk and
patterns of multimorbidity on patient-relevant outcomes
(such as activities of daily living, self-rated physical
health, self-rated mental health and social participation),
interventions for community-dwelling older adults with
multimorbidity and the strengths and limitations in
reporting on multimorbidity with health survey data and
administrative data. The implications for research
included: 1) the need to move the study of multimorbid-
ity beyond simply counting number of chronic condi-
tions; 2) the need to incorporate patient-reported
outcomes in the study of multimorbidity moving for-
ward; and 3) the importance of exploring the heteroge-
neity within multimorbidity at the population-level (such
as with population stratification) to better inform cross-
national comparisons.
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Special guest presentations
The symposium then included three speakers with exten-
sive clinical and research expertise on multimorbidity.
These presentations showcased completed research pro-
grammes and ongoing training programmes from three dif-
ferent countries (Canada, the United States and Ireland).
The first presentation was by Professor Martin Fortin
(Université de Sherbrooke) who discussed key learning
from the Patient-Centred Innovations for Persons with
Multimorbidity (PACEinMM) programme,8 which was a
five-year multidisciplinary research study funded by Cana-
dian Institutes of Health Research (CIHR) Signature Initia-
tive.9 During this work, the PACEinMM research team
developed a new framework for effective interventions for
multimorbidity, created new measures for use by other
research teams such as the ‘Research Tool to document
self-reported chronic conditions in primary care’ and the
‘Patient-centred coordination by a care team’.10,11 The
research programme also included a transformation or
alignment of two existing chronic diseases prevention and
management initiatives, which were then evaluated using a
purposeful mixed-methods approach.12
The second presentation was by Dr. Mayra Tisminetzky
(University of Massachusetts Medical School and the
Meyers Primary Care Institute) who discussed the Advan-
cing Geriatrics Infrastructure and Network Growth
(AGING) Initiative, which is a joint endeavour of the
Health Care Systems Research Network and Older Amer-
icans Independence Centers (also known as ‘Pepper Cen-
ters’). The overall aim of the AGING Initiative is to
improve the study of multimorbidity,13,14 which has been
facilitated by the successful development of a repository of
measurements and analytic tools, research-ready datasets,
support for research projects to move from the pilot stage to
multidisciplinary and multi-site research programmes. The
AGING Initiative includes the MCC (Multiple Chronic
Conditions) Scholars Program to support cohorts of future
experts on multimorbidity and the Patient/Caregiver Advi-
sory Council to advise the AGING Initiative leadership on
strategies for engaging patients and caregivers in all stages
of the research process.
The third presentation was by Professor Susan Smith
(Royal College of Surgeons in Ireland) who discussed the
Health Research Board Collaborative Doctoral Award
Managing Complex Multimorbidity in Primary Care. This
is a nationally funded programme for a cohort of four mul-
tidisciplinary PhD students each year, which aims to inform
policy and practice to improve outcomes for patients who
are living with complex multimorbidity. The training pro-
gramme will build capacity in multimorbidity research and
includes core training modules, institutional supports, a
scientific advisory group and collaboration withinterna-
tional partners and mentors. The four current PhD projects
address different priorities in multimorbidity, specifically
examining medication adherence among patients; the
impact of clinical practice guidelines on patient costs; a
randomized controlled trial (RCT) of linkworkers to sup-
port health and social care coordination; and a pilot cluster
RCT of a family practice-based pharmacy intervention to
address prescribing challenges. The overarching aim of the
programme is to incorporate patient and public involve-
ment in the design of interventions and guidelines, thus
training the PhD students in meaningful research projects
and ensuring reduced treatment burden for participating
patients.
Elevator pitch presentations
Next, there were eleven five-minute and five-slide presen-
tations that showcased either ongoing or completed
research work related to multimorbidity. There were many
topics covered by these eleven researchers from a variety of
training levels (undergraduate, graduate and post-doctoral
trainees, as well as both junior and mid-career researchers)
and countries (Belgium, Canada, The Netherlands, Russia,
Singapore and the United States). The topics covered in the
presentations included the epidemiology and patterns of
multimorbidity and polypharmacy in various countries,
methodological approaches for the measurement of multi-
morbidity, multimorbidity burden in more specific sub-
populations (such as psychosis or heart failure patients),
opportunities for better management of patients with multi-
morbidity using digital health interventions and the uptake
of preventive services between those with and without mul-
timorbidity. The abstracts of these presentations are avail-
able upon request.
Breakout sessions
The objective of these breakout sessions was to facilitate
discussion to address the next frontiers of multimorbidity
research in the respective areas, as well as how to purpose-
fully engage with patients, caregivers and international col-
leagues in future research. Summaries of the discussion
were prepared based on notes taken by observers, analysis
of slides from the symposium presentations and content-
checking with co-authors of these proceedings.
Multimorbidity and the intersection between primary
care and public health
There were three key frontiers of research for this topic.
The first was employing patient-engaged system design
whereby citizens and patients are engaged from the outset
in any health system design consistent with a patient-
oriented approach to research. The second frontier focused
on the concept of ‘intrinsic-capacity’, a concept that may be
relevant for both patients with multimorbidity and their
caregivers who often have their own health issues. Intrinsic
capacity is contrasted against frailty15 and is defined by the
World Health Organization as ‘the composite of all
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physical and mental capacities that an individual can draw
upon during his/her life’.16 The participants of this topic
discussed how focusing on intrinsic capacity might provide
a positive framework in which to conduct multimorbidity
research, specifically focusing on capacity instead of defi-
cit. The third frontier was a focus on prevention of multi-
morbidity and minimizing its effects by including programs
that cross primary care and public health (such as programs
that utilize physical activity for treatment and prevention).
Multimorbidity and data sources
The key frontiers of research for this topic included a focus
on using more comprehensive clinical data with more
advanced approaches like artificial intelligence and natural
language processing. This next stage of research will
require interdisciplinary collaboration between both clini-
cians (such as primary care providers) and analysts (such as
epidemiologists or computer scientists). Furthermore,
incorporating patient-relevant outcomes will help research-
ers understand heterogeneity in multimorbidity experience
among patients and their caregivers. As well, applying a
tailored approach with precision or personalized medicine
will be ideal to address health needs (based on genetic,
environmental, lifestyle and capacity factors) and personal
goals within the context of complexity, while research
focused on pharmacogenetics can be used for more sophis-
ticated risk prediction modelling across populations. Each
of these interrelated avenues of exploring multimorbidity
within diverse data sources was discussed in this breakout
session.
Equally important is to purposefully involve patients
and caregivers in multimorbidity research, which has been
acknowledged in recent publications.1,17 This involvement
should be a collaborative and respectful partnership
between patients and caregivers with their lived experi-
ences, which can then inform the development of a research
project. For example, this partnership can inform the devel-
opment of meaningful research questions, appropriate
study design, relevant outcome measures, effective disse-
mination of findings and appropriate next steps. Realisti-
cally, this partnership can also range from active
engagement to knowledge sharing based on the capacity
of patients and caregivers to be involved throughout the
research process. However, it is ideal that this involvement
should be supported by outlining and negotiating the role of
the patients, caregivers and researchers beforehand and to
clearly articulate roles and expectations.
Future research could support purposeful engagement of
colleagues through international benchmarking studies to
explore multimorbidity across different contexts. For
example, recent publications have focused on a compre-
hensive review of indices measuring multimorbidity
beyond counting diseases18 and clear recommendation on
a core outcome set for research on multimorbidity.19
Funding opportunities like the Horizon 2020/Horizon
Europe and the Wellcome Trust were identified as poten-
tial supporters for cross-national and collaborative stud-
ies. However, it was agreed that non-funded progress
could be made by research teams supporting the develop-
ment of consensus statements on various topics related to
multimorbidity, such as through online communities like
the International Research Community on Multimorbid-
ity.20 This approach has previously proven effective as
demonstrated by recommendations from Smith et al. on
the design and evaluation of interventions to improve out-
comes for patients living with multimorbidity, which
came from a forum discussion held at the North American
Primary Care Research Group (NAPCRG) Annual Meet-
ing in 2012.21
Key themes and next steps
The key priorities and recommendations for future research
from the various presentations during the symposium have
been synthesized in Table 1. In addition to building on the
areas of future work as identified in the Keynote Presenta-
tions and the Breakout Sessions, there were common
themes throughout the symposium discussion. These com-
mon themes included: 1) the need for collaborative inter-
national partnerships (supported by patient and caregiver
involvement in research whenever possible); 2) the need to
define multimorbidity beyond disease counting to incorpo-
rate patient and caregiver perspectives and to include
outcomes relevant to patients such as quality of life and
goal-oriented care; 3) the potential of scaling and spreading
innovations in the health care system that create necessary
shifts from disease-focused to patient-centred; and 4) the
potential that can come from purposeful integration of pri-
mary care and public health to improve both clinical man-
agement and prevention of multimorbidity by tackling both
downstream and upstream factors.2
It is important to acknowledge that a limitation of this
symposium is that countries with an active programme of
innovation and research in relation to multimorbidity were
not represented in the attendance (for example: Australia,
Brazil, Denmark, England, New Zealand or Spain). While
this was due to limited budgets, future virtual events could
be more inclusive. Likewise, we must acknowledge that
three of the five plenary speakers were editors-in-chief of
this journal (which was appropriate as they are leading
experts in this field), but external reviewers reviewed this
article to avoid potential conflicts of interest.
A notable outcome from this symposium has been plan-
ning future in-person meetings, including the submission of
applications for funding between cross-national collabora-
tors. These in-person events will be supplemented by
online webinars and workshops, which are currently being
planned to facilitate continued international community-
building. These events will be shared through online
sources, specifically the Journal of Comorbidity and the
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International Community on Multimorbidity (http://
crmcspl-blog.recherche.usherbrooke.ca/). The Journal of
Comorbidity was highlighted as a primary resource for
multimorbidity research and attendees acknowledged the
need for both authors and reviewers for this journal. Finally,
it was well-acknowledged among the attendees that expand-
ing the collaboration and discussion among international
colleagues via in-person and virtual meetings will be
important to move multimorbidity research forward.
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